NCT00053924 Perifosine in Treating Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00053222 Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine Status COMPLETED Phase PHASE2
NCT00051467 A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00049608 Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00049348 Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00047710 Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00045747 UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00044031 Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma Status COMPLETED Phase PHASE3
NCT00042939 Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00040833 Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00040183 OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. Status COMPLETED Phase PHASE3
NCT00040092 A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00033735 Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00033384 CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00033241 Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT00032175 Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00031837 Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT00030732 Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT00027534 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00027521 Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer Status WITHDRAWN Phase PHASE1